Company Comparison
Editas Medicine vs BioDefense Pro
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Editas Medicine | BioDefense Pro |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | located in Cambridge, Massachusetts | Cambridge |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | Seed |
| Total Funding | — | $11M |
| Valuation | — | — |
What They Build
Editas Medicine
Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology.
BioDefense Pro
A Cambridge-based biotech company developing biotechnology solutions for biodefense and biosecurity applications.
Key Investors
Editas Medicine
BioDefense Pro
No investors listed.
Sector Overlap
Both Editas Medicine and BioDefense Pro operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
14-day free trial. No credit card required.